{"id":79274,"date":"2023-07-07T08:45:34","date_gmt":"2023-07-07T08:45:34","guid":{"rendered":"https:\/\/dailytalks.org\/?p=79274"},"modified":"2023-07-07T08:45:34","modified_gmt":"2023-07-07T08:45:34","slug":"bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=79274","title":{"rendered":"Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics"},"content":{"rendered":"<p>Berlin, June 5, 2023 \u2013 Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas\u2019 LNP technology will support Bayer\u2019s in vivo gene editing and protein replacement programs by specifically delivering RNA payloads to the desired target organ&#8230;<br \/><a href=\"https:\/\/www.bayer.com\/media\/en-us\/bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Berlin, June 5, 2023 \u2013 Bayer AG is joining forces with Acuitas Therapeutics, Inc., a<\/p>\n","protected":false},"author":1,"featured_media":79275,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-79274","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics.jpg",1200,630,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-300x158.jpg",300,158,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-768x403.jpg",640,336,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-1024x538.jpg",640,336,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics.jpg",1200,630,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics.jpg",1200,630,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-1024x538.jpg",1024,538,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/07\/79274-bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/79274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=79274"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/79274\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/79275"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=79274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=79274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=79274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}